Published in:
01-03-2013 | Educational Review
Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO
Authors:
Rebecca M. Lombel, Elisabeth M. Hodson, Debbie S. Gipson
Published in:
Pediatric Nephrology
|
Issue 3/2013
Login to get access
Abstract
Kidney Disease: Improving Global Outcomes (KDIGO) recently published the clinical practice guideline on glomerulonephritis (GN) to assist the practitioner caring for patients with GN. Chapter 4 of the guideline focuses on managing children aged 1–18 years with steroid-resistant nephrotic syndrome (SRNS), defined by an inability to achieve complete remission with corticosteroid therapy. Guideline development followed a thorough evidence review, and management recommendations and suggestions were based on the best available evidence. Limitations of the evidence, including the paucity of large-scale randomized controlled trials, are discussed. This article provides both the guideline recommendations and a brief review of relevant treatment trials related to each recommendation. This précis serves as a summary of the complete guidelines recently published.